Advertisement
Original Communications| Volume 125, ISSUE 1, P33-40, January 1999

L-arginine attenuates endothelial dysfunction in endotoxin-induced lung injury

      Abstract

      Background: Pulmonary vasorelaxation to endothelium-dependent and independent agonists is dysfunctional in endotoxin-induced acute lung injury. L-arginine is the precursor to endothelial production of nitric oxide (NO), suggesting that arginine and NO are intimately linked. We hypothesized that L-arginine would attenuate endotoxin-induced dysfunction of guanosine 3′, 5′-cyclic monophosphate-mediated pulmonary vasorelaxation. Methods: Concentration-response curves were generated for acetylcholine, calcium ionophore A23187, and sodium nitroprusside (SNP) in isolated phenylepherine-preconstricted pulmonary artery rings (10-9 to 10-6 mol/L) 4 hours after endotoxin (500 mg/kg intraperitoneal) or saline injection. The effect of L-arginine in vitro was determined with L- or D-arginine (50 mmol/L) 30 minutes before dose response. Results: Endothelium-dependent pulmonary vasorelaxation was dysfunctional after endotoxin injection as demonstrated by impaired responses to acetylcholine and A23187 (P < .05 vs control). Endotoxin-induced dysfunction of these endothelium-dependent responses was attenuated by L-arginine (P < .05 vs endotoxin). Endothelium-independent vasorelaxation (SNP) was also dysfunctional after endotoxin treatment (P < .05 vs control). L-arginine failed to attenuate the endotoxin-induced dysfunction of the response to SNP. The concentration responses for endothelium-dependent and independent vasorelaxing agonists in endotoxin-treated rats were not influenced by D-arginine. Conclusion: L-arginine supplementation attenuates endotoxin-induced dysfunction of endothelium-dependent pulmonary vasorelaxation. (Surgery 1999;125:33-40.)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Chang SW
        • Feddersen CO
        • Henson PM
        • Voelkel NF.
        Platelet activating factor mediates hemodynamic changes and lung injury in endotoxin treated rats.
        J Clin Invest. 1987; 79: 1498-1509
        • Mclntyre RC
        • Banedee A
        • Agrafojo J
        • Fullerton DA.
        Pulmonary hypertension in acute lung injury is due to impaired vasodilatation with intact vascular contractility.
        J Surg Res. 1995; 58: 765-770
        • Fullerton DA
        • Hahn AR
        • Mclntyre RC.
        Mechanistic imbalance of pulmonary vasomotor control in progressive lung injury.
        Surgery. 1996; 119: 98-105
        • Kurrek MM
        • Zapol WM
        • Holzman A
        • Filippov G
        • Winkler M
        • Bloch KD.
        In vivo lipopolysaccharide pretreatment inhibits cGMP release from the isolated perfused rat lung.
        Am J Physiol. 1995; 269 (Lung Cell Mol Physiol 13): L618-L624
        • Spath JA
        • Sloane PJ
        • Gee MH
        • Albertine KH.
        Loss of endothelium-dependent vasodilation in pulmonary vessels of sheep after prolonged endotoxin.
        J Appl Physiol. 1994; 76: 361-369
        • Sheridan BC
        • Mclntyre RC
        • Agrafojo J
        • Meldrum DR
        • Meng X
        • Fullerton DA.
        Neutrophil-depletion attenuates endotoxin-induced dysfunction of cGMP-mediated pulmonary vasorelaxation.
        Am J Physiol. 1996; 271: L820-L828
        • Fullerton DA
        • Mclntyre RC
        • Hahn AR
        • et al.
        Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury.
        Am J Physiol. 1995; 268: L1029-L1035
        • Ignarro LJ.
        Biosynthesis, and metabolism of endothelium-derived nitric oxide.
        Annu Rev Pharmacol Toxicol. 1990; 30: 535-560
        • Moncada S
        • Palmer RM
        • Higgs J.
        Nitric oxide: physiology, pathophysiology, and pharmacology.
        Pharmacol Rev. 1991; 43: 109-142
        • Palmer RMJ
        • Rees DD
        • Ashton DS
        • Moncada S.
        L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation.
        Biochem Biophys Res Commun. 1988; 153: 1251-1256
        • Pan M
        • Wasa M
        • Lind S
        • Gertler J
        • Abbott W
        • Souba WW.
        TNF-stimulated arginine transport by human vascular endothelium requires activation of protein kinase C.
        Ann Surg. 1995; 221: 590-601
        • Pan M
        • Wasa M
        • Ryan U
        • Souba W.
        Lipopolysaccharide and tumor necrosis factor stimulate lung microvascular arginine uptake, a response attenuated by dexamethasone.
        J PEN. 1996; 20: 50-55
        • Parker JL
        • Adams HR
        Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxin.
        Circ Res. 1993; 72: 539-551
        • Liu SF
        • Barnes PJ
        • Evans TW.
        Time course and cellular localization of lipopolysaccharide-induced inducible nitric oxide synthase messenger RNA expression in the rat in vivo.
        Crit Care Med. 1997; 25: 512-518
        • Fullerton DA
        • Eisenach JH
        • Mclntyre RC
        • et al.
        Inhaled nitric oxide prevents lung neutrophil accumulation and pulmonary endothelial dysfunction after mesenteric ischemia reperfusion.
        Am J Physiol. 1996; 271: L326-L331
        • Huttemeier PC
        • Watkins WD
        • Peterson MB
        • Zapol WM.
        Acute pulmonary hypertension and lung thromboxane release after endotoxin infusion in normal and leukopenic sheep.
        Circ Res. 1982; 50: 688-694
        • Meyrick BO
        • Brigham KL
        Acute effects of Escherichia coli endotoxin on the pulmonary microcirculation of anesthetized sheep.
        Lab Invest. 1983; 48: 458-470
        • Heflin AC
        • Brigham KL.
        Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia.
        J Clin Invest. 1981; 68: 1253-1260
        • Hinson J
        • Hutchinson A
        • Ogletree M
        • Brigham KL
        • Snapper J.
        Effect of granulocyte depletion on altered lung mechanics after endotoxemia in sheep.
        J Appl Physiol. 1983; 55: 92-99
        • Worthen GS
        • Haslett C
        • Rees AJ
        • Gumbay RS
        • Hensen JE
        • Hensen PM.
        Neutrophil-mediated pulmonary vascular injury: synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung.
        Am Rev Respir Dis. 1987; 136: 19-28
        • Fink MP
        • Heard SH.
        Laboratory models of sepsis and shock.
        J Surg Res. 1990; 49: 186-196
        • Granger DL
        • Hibbs JB
        • Perfect JR
        • Durack DT.
        Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages.
        J Cin Invest. 1988; 81: 1129-1136
        • Iyenger R
        • Steuhr DJ
        • Marletta MA.
        Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst.
        Proc Natl Acad Sci USA. 1987; 84: 6369-6373
        • Palmer RMJ
        • Ferrige AG
        • Moncada S.
        Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
        Nature Lond. 1987; 327: 525-526
        • McQueston JA
        • Cornfield DN
        • McMurtry IF
        • Abman SH.
        Effects of oxygen and exogenous L-arginine on EDRF activity in fetal pulmonary circulation.
        Am J Physiol. 1993; 264: H865-H871
        • Rossitch E
        • Alexander E
        • Black PM
        • Cooke JP.
        L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits.
        J Clin Invest. 1991; 87: 1295-1299
        • Nakanishi K
        • Vinten-Johansen J
        • Lefer DJ
        • et al.
        Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size.
        Am J Physiol. 1992; 263: H1650-H1658
        • Rudinsky B
        • Bell A
        • Hipps R
        • Meadow W.
        The effects of intravenous L-arginine supplementation on systemic and pulmonary hemodynamics and oxygen utilization during group B streptococcal sepsis in piglets.
        J Crit Care. 1994; 9: 34-46
        • Girerd XJ
        • Hirsch AT
        • Cooke JP
        • Dzau VJ
        • Creager MA.
        L-arginine augments endothelium-dependent vasodilatation in cholesterol-fed rabbits.
        Circ Res. 1990; 67: 1301-1308
        • Chen PY
        • Sanders PW.
        L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats.
        J Clin Invest. 1991; 88: 1559-1567
        • Gold ME
        • Bush PA
        • Ignarro LJ.
        Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation.
        Biochem Biophys Res Commun. 1989; 164: 714-721